Parallel Import Diversion Control

Parallel Import Diversion Control is a regulatory and supply chain management framework designed to prevent the unauthorized routing of legitimately manufactured pharmaceutical products from authorized markets into restricted or unintended markets, thereby mitigating the risk of counterfeit medicine infiltration through diversion channels.

5

Publications

292

Citations

14

Authors

10

Institutions

Publications per year

2017–2026

3

Authors

14

  1. SX
    Stuart X. Zhu

    University of Groningen, Netherlands

    1 publications · 35 citations

    1

    h-index

  2. LE
    Leopoldo Eduardo Cárdenas‐Barrón

    Tecnológico de Monterrey, Mexico

    1 publications · 69 citations

    1

    h-index

  3. MR
    Martin Richardson

    University of Otago, New Zealand

    1 publications · 100 citations

    1

    h-index

  4. LS
    Lluís Saurí

    Frankfurt School of Finance & Management, Germany

    1 publications · 13 citations

    1

    h-index

  5. HZ
    Hans Zenger

    European Commission, Belgium

    1 publications · 13 citations

    1

    h-index

1–5 of 14

Venues

  1. Journal of Health Economics

    1 publications · 13 citations

    1

    h-index

  2. 1

    h-index

  3. International Journal of Production Economics

    1 publications · 69 citations

    1

    h-index

  4. Journal of International Economics

    1 publications · 100 citations

    1

    h-index

  5. Omega

    1 publications · 75 citations

    1

    h-index

1–5